(Q53519559)

English

Next-generation optimized biotherapeutics - A review and preclinical study.

scientific article published on 19 June 2014

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

title

Next-generation optimized biotherapeutics - A review and preclinical study. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

author name string

Tadashi Ueda

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

publication date

19 June 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

published in

Biochimica et Biophysica Acta

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

volume

1844

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

page(s)

2053-2057

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

cites work

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1074/JBC.M202069200

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-08-1776

Identifiers

DOI

10.1016/J.BBAPAP.2014.06.008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

Fatcat ID

release_riop6o66v5d4pbygncxswlxlqu

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/riop6o66v5d4pbygncxswlxlqu

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

24954894

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24954894

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/24954894

(Q53519559)

Next-generation optimized biotherapeutics - A review and preclinical study.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)